MCRB - Seres Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue32,10021,766--
Cost of Revenue89,45581,98938,09510,718
Gross Profit-57,355-60,223-38,095-10,718
Operating Expenses
Research Development----
Selling General and Administrative34,04032,61616,7614,364
Non Recurring----
Others----
Total Operating Expenses123,495114,60554,85615,082
Operating Income or Loss-91,395-92,839-54,856-15,082
Income from Continuing Operations
Total Other Income/Expenses Net2,0151,26076-1,627
Earnings Before Interest and Taxes-91,395-92,839-54,856-15,082
Interest Expense----209
Income Before Tax-89,380-91,579-54,780-16,709
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-89,380-91,579-54,780-16,709
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-89,380-91,579-54,780-16,709
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-89,380-91,579-54,780-18,000